Literature DB >> 31122420

A rapid, simple and sensitive liquid chromatography tandem mass spectrometry assay to determine amoxicillin concentrations in biological matrix of little volume.

Sebastian Franck1, Tania Fuhrmann-Selter2, Jan F Joseph3, Robin Michelet4, Fiordiligie Casilag5, Jean-Claude Sirard5, Sebastian G Wicha6, Charlotte Kloft7.   

Abstract

To assess pharmacokinetics of amoxicillin (AMX) in mice, limitations such as a small sampling volume and low drug concentrations have to be addressed. Similar challenges are faced in a clinical framework, e.g. for therapeutic drug monitoring in neonates or small-scale in vitro investigations. An assay enabling quantification of small sample volumes but still at very low concentrations covering a broad concentration range is thus needed. A simple, rapid and highly sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and successfully validated for quantification of AMX in mouse serum according to European Medicines Agency guidelines. Sample preparation enabled the use of only 10 μL of serum, which is 5-fold less than comparable assays and allows to reduce the number of mice used in pharmacokinetic studies. After protein precipitation with 40 μL chilled methanol and dilution of the supernatant with water, the sample was injected into the LC system on a Poroshell 120 Phenyl Hexyl column (2.1 × 100 mm, 2.7 μm). Chromatographic separation was achieved using a gradient method consisting of acetonitrile and ultra-pure water, both with 0.1% (V/V) formic acid. Positive electrospray ionisation in multiple reaction monitoring mode was used for detection and quantification of AMX. Application to murine study samples demonstrated the reliability of the developed method being accurate and precise with a quantification range from 0.01 to 10 μg/mL. The assay is easily transferable due to a simple sample preparation and confirmed stability of AMX under various applied conditions.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Amoxicillin; Bioanalytical method validation; LC-MS/MS; Mouse serum; Pharmacokinetics

Mesh:

Substances:

Year:  2019        PMID: 31122420     DOI: 10.1016/j.talanta.2019.03.098

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

1.  The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia.

Authors:  Robin Michelet; Moreno Ursino; Sandrine Boulet; Sebastian Franck; Fiordiligie Casilag; Mara Baldry; Jens Rolff; Madelé van Dyk; Sebastian G Wicha; Jean-Claude Sirard; Emmanuelle Comets; Sarah Zohar; Charlotte Kloft
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

2.  A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against S. pneumoniae in Mice.

Authors:  Sebastian Franck; Robin Michelet; Fiordiligie Casilag; Jean-Claude Sirard; Sebastian G Wicha; Charlotte Kloft
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.